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ABSTRACT
The polysaccharide capsule of Streptococcus pneumoniae is required for nasopharyngeal colonization and for invasive disease in
the lungs, blood, andmeninges. In contrast, the vast majority of conjunctival isolates are acapsular. The first serotype-specific
gene in the capsule operon, cpsE, encodes the initiating glycosyltransferase and is one of the few serotype-specific genes that can
tolerate null mutations. This report characterizes a spontaneously arising TIGR4mutant exhibiting a reduced capsule, caused by
a 6-nucleotide duplication in cpsEwhich results in duplication of Ala and Ile at positions 45 and 46. This strain (AI45dup) pos-
sessed more exposed phosphorylcholine and was hypersusceptible to C3 complement deposition compared to the wild type. Ac-
cordingly, the mutant was significantly better at forming abiotic biofilms and binding epithelial cells in vitro but was avirulent
in a sepsis model. In vitro serial passaging of the wild-type strain failed to reproduce the AI45dupmutation but instead led to a
variety of mutants with reduced capsule harboring single nucleotide polymorphisms (SNPs) in cpsE. A single passage in the sep-
sis model after high-dose inoculation readily yielded revertants of AI45dup with restored wild-type capsule level, but the major-
ity of SNP alleles of cpsE could not revert, suppress, or bypass. Analysis of cpsE in conjunctival isolates revealed a strain with a
single missense mutation at amino acid position 377, which was responsible for reduced encapsulation. This study supports the
hypothesis that spontaneous, nonreverting mutations in cpsE serve as a form of adaptive mutation by providing a selective ad-
vantage to S. pneumoniae in niches where expression of capsule is detrimental.
IMPORTANCE
While the capsule of Streptococcus pneumoniae is required for colonization and invasive disease, most conjunctival isolates are
acapsular by virtue of deletion of the entire capsular operon. We show that spontaneous acapsular mutants isolated in vitro har-
bor mostly nonrevertible single nucleotide polymorphism (SNP) null mutations in cpsE, encoding the initiating glycosyltrans-
ferase. From a small collection of acapsular conjunctival isolates, we identified one strain with a complete capsular operon but
containing a SNP in cpsE that we show is responsible for the acapsular phenotype. We propose that acapsular conjunctival iso-
lates may arise initially from such nonreverting SNP null mutations in cpsE, which can be followed later by deletion of portions
or all of the cps operon.
Streptococcus pneumoniae (the pneumococcus) is a Gram-posi-tive bacterium that is frequently found as a commensal organ-
ism of the human nasopharynx. However, depending on the site
of dissemination, it can also cause various invasive diseases, in-
cluding pneumonia, otitis media, sepsis, and meningitis (1–4).
One critical pneumococcal virulence factor is the capsular poly-
saccharide (capsule), of which over 90 different serotypes have
been characterized. The capsule has many important immune
evasion functions, including avoidance of mucus-mediated clear-
ance, entrapment in neutrophil extracellular traps (NETs), recog-
nition by complement factors, and opsonophagocytosis (5–9). Al-
though capsule is required for dissemination and invasive disease,
during asymptomatic nasopharyngeal colonization, a reduced
level of capsule is favored. Previous reports demonstrated that less
encapsulated strains more effectively interact with host epithelial
cells and form biofilms, both of which facilitate the persistence of
pneumococcus in the nasopharynx (10–15). Interestingly, while
capsule is necessary for invasive disease in the lungs, blood, and
meninges, the vast majority of pneumococcal strains that cause
conjunctivitis are acapsular (1–4, 16–18). These nontypeable
(NT) conjunctival isolates are classified into two subgroups de-
pending on the genetic structure of their capsule biosynthesis (cps)
locus. Group I NT strains possess a cps locus very similar to that of
encapsulated strains. Group II NT strains lack the vast majority of
the cps locus and instead harbor other genes, such as pspK (encod-
ing an LPXTG-anchored protein potentially involved in epithelial
adhesion and invasion), nspA [encoding a novel surface protein
which may interact with the human poly(Ig) receptor], and genes
with significant sequence similarity to aliB, which encodes a pep-
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tide-binding molecule associated with an ABC transporter (19–
23). While it is clear that the replacement of the entire cps locus
results in an acapsular strain, the molecular mechanism(s) re-
sponsible for reduced/loss of capsule in conjunctival clinical iso-
lates with a seemingly intact cps locus is incompletely understood.
The chemical composition and linkages between polysaccha-
ride subunits distinguish one capsular serotype from another (10–
15, 24–28). All serotypes, except for types 3 and 37, are synthesized
in a Wzx flippase/Wzy polymerase-dependent fashion (1, 25, 29,
30). The cps locus consists of approximately 15 genes that encode
all of the enzymes required for capsule synthesis and is arranged in
a cassette structure positioned between the conserved genes dexB
and aliA. Additionally, the entire cps operon is flanked by inser-
tion sequences, which potentially facilitate the exchange of genetic
material between pneumococcal strains, thus yielding capsular
switch mutants (25, 31, 32). With the exception of serotypes 3 and
37, the first four genes, cpsA to cpsD, are highly conserved and
encode regulatory proteins (25, 27, 33–35). The region down-
stream of cpsD is unique to each serotype and encodes glycosyl
transferases, polymerases, transporters, enzymes involved in
sugar nucleotide synthesis, Wzx flippase, and Wzy polymerase
(27). Importantly, cpsE is the first serotype-specific gene and en-
codes the initiating glycosyltransferase that catalyzes the linkage of
the sugar-phosphate to the lipid acceptor on the cytoplasmic face
of the cell membrane (36–38). Mutations in cpsE, including sim-
ple sequence repeats within this gene, have been shown to reduce
levels of encapsulation and may potentially represent another
layer of complexity in the scheme of capsular polysaccharide reg-
ulation (36, 39–42).
This study begins with the characterization of a spontaneously
arising mutant of TIGR4 (serotype 4) that exhibited reduced cap-
sule expression. This mutant harbored a 6-bp duplication in
cps4E, which was readily reversible following in vivo passage in the
blood. Upon in vitro serial passaging of TIGR4 and screening for
colony variants, additional unique mutants with reduced capsule
expression were identified, all of which contained single nucleo-
tide polymorphisms (SNPs) in cps4E representing missense or
nonsense mutations. In contrast to the 6-bp duplication, the ma-
jority of the cps4E SNP mutations were not reversible following in
vivo passage. From the available conjunctival isolates with an in-
tact cps operon, we identified two serotype-matched (serotype
19A) variants containing SNP missense mutations in cpsE. One of
these mutations was shown to be responsible for the acapsular
phenotype by genetically reverting the mutation. This report de-
scribes the phenotypes for naturally occurring cpsE mutant pop-
ulations and discusses the potential relevance to pneumococcal
conjunctivitis.
MATERIALS AND METHODS
Bacterial strains and growth conditions. S. pneumoniae TIGR4 and its
unencapsulated derivative AC4421 were from our laboratory stocks. For
indicated experiments, encapsulated and unencapsulated conjunctival
isolates (serotype 19A) were utilized (43).
S. pneumoniae was grown in or on the following media at 37°C in a 5%
CO2 incubator: Todd-Hewitt yeast extract broth (THY), which was com-
posed of Todd-Hewitt broth (Becton Dickinson, Co.) supplemented with
0.5% yeast extract (Fischer Scientific, Inc.) and 5l/ml Oxyrase (Oxyrase,
Inc.); blood agar plates (BA), which are tryptic soy agar plates supple-
mented with 5% (vol/vol) sheep blood (Northeast Laboratories, Inc.); and
Trypticase soy agar (TSA) plates supplemented with5,600 units of cat-
alase (Worthington Biochemical Corporation). Where appropriate,
streptomycin (Sm; 100 g/ml) was added to the medium.
Serial passaging, screening of colonies, and sequencing of cpsE in
capsule mutants. S. pneumoniae TIGR4 was plated on BA plates and
grown overnight. Ninety-six randomly picked colonies were transferred
using toothpicks to a 96-well, flat-bottom plate containing 100l of THY
and incubated until the cultures reached mid-exponential phase, approx-
imately 4 to 6 h. By using a 96-well pin replicator, the cultures were
stamped onto a large BA plate and incubated overnight. This growth on
BA plates and in THY was repeated for a total of 8 cycles. The final stamp-
ing of the 96 strains was done on TSA plates lacking blood to allow iden-
tification of bacterial growth with transparent morphology using oblique
transmitted light microscopy.
Twenty-six stamped areas showing the transparent phenotype were
restreaked for single colonies on TSA plates to visually confirm that the
population was homogenously transparent. Unpassaged and passaged
opaque colonies were also isolated as controls. Genomic DNA was iso-
lated from these strains, and the cps4E gene was PCR amplified using
primers in the flanking genes (Table 1). Sanger sequencing was used to
determine the cps4E genotype of each strain of interest. To confirm that
the cps4E mutation was solely responsible for the reduction in capsule
level, the mutant allele was moved in a clean wild-type (WT) TIGR4
background, and the resultant panel of isogenic cps4E mutants was exam-
ined by India ink staining and microscopy. These cps4E mutants were
further characterized using assays detailed below.
Construction of cpsE mutant strains. Mutant strains created during
this study are described in Table 1 and were generated by allelic exchange.
Each allelic exchange construct was generated in vitro using splicing by
overlap extension PCR (44). The upstream and downstream arms of ho-
mology flanking cpsE were PCR amplified from TIGR4, MGMV 3105, or
MGMV 3526 genomic DNA (gDNA) where appropriate. To aid in mak-
ing cpsE mutants, a streptomycin resistance (Smr) construct, conferred by
a point mutation in the rpsL gene (45), was also included during the
transformation process. Transformation of S. pneumoniae was done as
previously described (46). All cpsE mutations were confirmed by DNA
sequencing, and mutants were confirmed to have reduced capsule levels
by India ink staining.
C3deposition, exposed phosphorylcholine (P-Cho), capsule assays,
and fluorescence-activated cell sorting (FACS) analysis. For C3 deposi-
tion assays, 1 ml of mid-exponential-phase bacteria grown in THY was
pelleted, washed in phosphate-buffered saline (PBS), and resuspended in
500l of Hanks buffer with Ca2 and Mg2 (Gibco Corp.) supplemented
with 0.1% gelatin (Fischer Scientific, Inc.). A total of 107 CFU in 50 l
were added to a final concentration of 10% infant rabbit serum in 100 l
(AbD Serotec, Co.). Samples were incubated in a 37°C rolling incubator
for 30 min. Next, opsonization reaction mixtures were chilled for 3 min
on ice, quenched with 500 l of Hanks buffer without Ca2 and Mg2
(Gibco) with 0.1% gelatin, and pelleted at 4,000 rpm for 5 min. Pellets
were resuspended in 1:200 fluorescein isothiocyanate (FITC)-conjugated
goat anti-rabbit C3 antibody (MP Biomedicals) in 100 l Hanks buffer
without Ca2 and Mg2 with 0.1% gelatin and incubated on ice in the
dark for 30 min. Staining reactions were quenched with 500 l Hanks
buffer with 0.1% gelatin but without Ca2 and Mg2, the mixtures were
centrifuged at 4,000 rpm for 5 min, and pellets were resuspended in 300l
of 2% paraformaldehyde (PFA; Sigma-Aldrich Co.).
For exposed P-Cho and capsule assays, 250 l of mid-exponential-
phase bacteria grown in THY were pelleted and washed in PBS. Pellets
were resuspended in 100 l of unconjugated mouse IgA anti-P-Cho (1:
100; Sigma-Aldrich) or rabbit anti-serotype 4 (1:2,500; Statens Serum
Institut) serum in PBS and incubated on ice for 30 min. Samples were
quenched with 500l PBS and centrifuged at 4,000 rpm for 5 min. Pellets
were resuspended in 100 l of phycoerythrin-conjugated rat anti-mouse
IgA (1:100) or FITC-conjugated goat anti-rabbit secondary antibodies in
PBS and kept on ice in the dark for 30 min. Staining reactions were
quenched with 500 l PBS, and the mixtures were pelleted, resuspended
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in 300 l 2% PFA, and analyzed as described above. All samples were
collected (25,000 events) on a FACSCalibur analytical flow cytometer,
analyzed, and plotted using Flowlogic (Inivai Technologies).
Epithelial adhesionandabiotic biofilm formationassays.For abiotic
biofilm experiments, mid-exponential-phase cultures grown in THY were
back-diluted to an optical density at 600 nm (OD600) of 0.01 in fresh THY,
and 200 l was plated in 96-well plates in replicates of five and incubated
for 18 h. Wells were washed three times with 250l PBS, stained with 250
l of 0.05% (wt/vol) crystal violet in PBS, and incubated for 30 min at
room temperature. Subsequently, the crystal violet solution was aspirated
from the wells, and wells were washed once with 280 l PBS. Stained
biofilms were dissolved in 250 l of 95% ethanol, and the OD was read at
570 nm.
For epithelial adhesion experiments, 1 ml of mid-exponential-phase
cultures grown in THY was pelleted, washed in PBS, and resuspended to
107 CFU/ml in PBS. One milliliter of culture was added to triplicate wells
in 24-well plates containing confluent monolayers of A549 human lung
carcinoma cells, and plates were centrifuged for 5 min at 2,500 rpm to
initiate contact between pneumococci and host cells and incubated at
37°C for 2 h. Nonadherent bacteria were aspirated off cells, and wells were
washed thoroughly with 1 ml of PBS. Wells were then treated with 200 l
of 0.125% trypsin-EDTA and incubated for 5 min at 37°C. Next, 300l of
0.025% Triton X-100 was added to wells followed by thorough pipetting
to lyse host cells. The released bacteria were serially diluted and plated on
BA for enumeration. Data are presented as the percentage of input bacte-
ria bound and are normalized to the calculated number of total input
bacteria.
Animal infections.All experiments used female Swiss Webster mice, 6
to 9 weeks old (Taconic Laboratories). All animal experiments were per-
formed in accordance with NIH guidelines, the Animal Welfare Act, and
U.S. federal law. The experimental protocol used for this study was ap-
proved by the Tufts University School of Medicine’s Institutional Animal
Care and Use Committee. Mice used for these experiments were housed in
an AAALAC-accredited research animal facility. Strains of interest were
grown to mid-exponential phase in THY, pelleted for 4 min at 4,000 rpm,
and washed in PBS. For blood infections, mice received103 or 108 CFU
in 100l by intraperitoneal (i.p.) injection. Mice were euthanized 18 to 24
h postinfection by CO2 asphyxiation. To recover bacteria from the blood,
TABLE 1 Relevant strains and primers used in this study
Strain or primer Descriptiona or sequence (5=–3=)
Strains
AC316 (TIGR4) Wild-type serotype 4 strain, Gmr
AC4421 (TIGR4cps) Serotype 4 strain with cps locus replaced with Cmr cassette
MGS023 (TIGR4 AI45dup) Serotype 4 strain with an in-frame addition of alanine and isoleucine at position 45 in Cps4E, Gmr
Smr
MGS024 (TIGR4 A42E) Serotype 4 strain; mutation A42E in Cps4E, Gmr Smr
MGS025 (TIGR4 A79E) Serotype 4 strain; mutation A79E in Cps4E, Gmr Smr
MGS026 (TIGR4 Y89*) Serotype 4 strain; mutation Y89* in Cps4E, Gmr Smr
MGS027 (TIGR4 D141*) Serotype 4 strain; mutation D141* in Cps4E, Gmr Smr
MGS028 (TIGR4 A156V) Serotype 4 strain; mutation A156V in Cps4E, Gmr Smr
MGS029 (TIGR4 G201S) Serotype 4 strain; mutation G201S in Cps4E, Gmr Smr
MGMV 3526 Serotype 19A, encapsulated conjunctival isolate
MGMV 3105 Serotype 19A, acapsular conjunctival isolate
MGS 3526 R377G Serotype 19A, conjunctival isolate with R377G mutation in cpsE
MGS 3105 G377R Serotype 19A, conjunctival isolate with G377R mutation in cpsE
Primers
For amplifying and sequencing cps4E
F cps4D GCGATACTCGAAATTCAGTTATGTTA
R cps4F CAAATATCTGACAACCTGAATGGTTCTGGC
F cps4E seq CCTTTTCGTTTCAGTACGTAAGGT
For generating AI45dup PhaseLocked mutants
F1 cps4C CAACACTGGAGGAGGCAA
R1 PhaseLock2 AAGTTTAATCGCGATGGCAATTGCAATTATGATAAAAAC
F2 PhaseLock2 TTGCAATTGCCATCGCGATTAAACTTGATTCAGAAGGTCC
R2 cps4F CCCAGGTATAGTACGAGAAACTATCGAG
R1 PhaseLock3 AAGTTTAATTGCGATGGCAATTGCAATTATGATAAAAAC
F2 PhaseLock3 TTGCAATTGCCATCGCAATTAAACTTGATTCAGAAGGTCC
For serotype 19A experiments
F cpsE ATGAGTGAAAAACTAGCAAAG
R cpsE CTATTTCGCTCCATCCTTC
F cpsE seq TCAAGTGGTATTGGAAGCGG
F1 cpsB TATTCATTCGCACATCGTCT
R1 MGMV 3526 R377G GTCCACTGTTGGTGGTCCTGTACCTACCAAACTCATATCTC
F2 MGMV 3526 R377G TAGGTACAGGACCACCAACAGTGGACGAGTATGAGCACTATA
R1 MGMV 3105 G377R GTCCACTGTTGGTGGTCCTGTACCTACCAAACTCATATCTC
F2 MGMV 3105 G377R TAGGTACACGACCACCAACAGTGGACGAGTATGAGCACTATA
R2 cpsH CACCCTCGTTTTCTTTCATCAA
a Gmr, gentamicin resistant; Smr, streptomycin resistant; Cmr, chloramphenicol resistant. * denotes a mutation that resulted in a stop codon.
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500 l of blood was removed by cardiac puncture, and clotting was pre-
vented by the addition of 3l of 500 mM EDTA. Serial dilutions of recov-
ered bacteria from each mouse were plated on BA, supplemented with Sm
(100 g/ml) when appropriate.
India ink staining for visualizing capsule. To qualitatively visualize
the pneumococcal capsule in strains of interest, 300 l of mid-exponen-
tial-phase bacteria grown in THY were pelleted and washed with PBS, and
pellets were resuspended in 100 l of PBS. India ink wet mounts were
made by adding 8l of bacteria to 2l of India ink and were visualized on
a Nikon Eclipse 80i with a 100 objective. Images were captured using a
Photometrics CoolSnap HQ camera, and pictures were visualized using
Roper Scientific software. When this negative-staining technique is used,
the pneumococcal cell appears dark and is surrounded by a white halo,
which is a result of the exclusion of India ink particles by the capsule.
Statistical analysis. Wilcoxon-signed rank tests and one-way analysis
of variance (ANOVA) were performed where indicated using GraphPad
Prism (GraphPad Software, Inc.).
RESULTS
Analysis of a spontaneousTIGR4mutantwith reduced capsular
polysaccharide. During a routine measurement of capsule ex-
pression in a culture of wild-type (WT) TIGR4 by flow cytometry,
we noticed there was an unusual subpopulation of cells exhibiting
reduced capsule level (data not shown). When we plated a portion
of this culture on TSA and examined colonies by oblique trans-
mitted light microscopy, we observed a heterogeneous population
with distinct transparent and opaque colony morphologies (Fig.
1A). The two colony types were genetically stable, yielding high
and low capsule expression, respectively, for the opaque and
transparent types (data not shown). Since mutations in the cpsE
gene, which encodes the initiating glycosyltransferase (38), were
reported to result in a reduction of capsule expression (39, 41, 42),
we sequenced this gene in both transparent and opaque variants.
These data revealed that, while the opaque strain had a wild-type
cps4E sequence, the transparent variant possessed a duplication of
a 6-nucleotide sequence, GCGATT, which results in the addition
of an alanine and isoleucine after amino acid 45 (Fig. 1B; also, see
Fig. 4B). We refer to this strain as the AI45dup-containing mu-
tant. Interestingly, in a phase-variable serotype 8 strain of pneu-
mococcus, caused by a 223-bp sequence duplication event in cpsE
that yields a premature stop codon and acapsular phenotype, the
duplication sequence also starts with the GCGATT sequence (41),
which led us to speculate that cps4E was also a phase-variable
locus. Our subsequent in vitro and in vivo experiments aimed to
elucidate the functional consequences of reduced encapsulation
in the AI45dup-containing mutant strain.
The AI45dup mutation does not result in complete loss of cap-
sule. However, by flow-cytometric analysis, this strain possesses
an approximately 10-fold reduction in capsule compared to the
WT (Fig. 2A). Since an inverse correlation between exposed P-
Cho and capsule expression was reported (47), we stained
AI45dup-containing mutant cells with a P-Cho-specific monoclo-
nal antibody (TEPC-15) to determine its P-Cho phenotype. Con-
sistent with having a reduced capsule level, the AI45dup-contain-
ing strain exhibits more exposed P-Cho than the WT strain and
has a phenotype more similar to that of the TIGR4cps strain (Fig.
2B). In order to examine the functional consequences of the
AI45dup mutation, we tested this strain in abiotic, static biofilm
and epithelial cell adhesion assays. Since a reduction in capsular
polysaccharide results in the exposure of underlying surface mol-
ecules involved in biofilm formation (13) and epithelial cell adhe-
sion (48–50), we anticipated that the AI45dup-containing mutant
would demonstrate an enhanced ability to form abiotic biofilms
and bind host cells. As shown in Fig. 2C and D, the AI45dup-
containing mutant is significantly better than WT TIGR4 at form-
ing abiotic biofilms and adhering to A549 human lung carcinoma
cells. While the AI45dup-containing strain was comparably better
than even the TIGR4cps strain, this difference was not statisti-
cally different in either assay.
Capsule level has also been reported to influence susceptibility
to complement deposition, opsonophagocytosis, and virulence in
models of sepsis. Less encapsulated strains are more susceptible to
C3 deposition and neutrophil-mediated killing, while more en-
capsulated strains are more resistant to these processes and are
also more virulent during blood infections (7, 9, 51). Consistent
with these prior reports, as determined by flow cytometry, the
mean fluorescence intensity (MFI) for C3 bacterial cells from the
AI45dup-containing mutant is approximately 200-fold higher
than that of WT cells, indicating that this mutant is drastically
more susceptible to C3 deposition (Fig. 2E). Since capsule is in-
dispensable for causing disease in the blood (2, 52), we tested how
the reduced level of capsular polysaccharide in the AI45dup-con-
FIG 1 Observation of a subpopulation of cells with reduced capsule levels in a wild-type TIGR4 strain and its cps4E genotype. (A) Cells from the TIGR4 sample
with a heterogeneous capsule phenotype were plated on TSA supplemented with catalase and were incubated overnight at 37°C with CO2. Colony morphology
was examined using oblique transmitted light microscopy. Arrows denote distinct transparent and opaque colonies. (B) Genomic DNA was isolated from
bacteria exhibiting transparent or opaque phenotypes, and the cps4E gene was sequenced and aligned to a TIGR4 reference genome. The schematic shows the
TIGR4 cps locus and location of the 6-bp, in-frame insertion of the sequence GCGATT present in transparent bacteria. The arrowhead upstream of cps4A
represents the cps promoter, Pcps. The light gray arrows are three IS elements upstream of the cps locus.
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taining mutant would affect its virulence in a mouse model of
sepsis. Mice were infected with either WT TIGR4 or the mutant
strain, and bacterial burden in the blood was determined after 18
h. Strikingly, the AI45dup-containing mutant was completely
avirulent at an infectious dose sufficient to cause significant mor-
bidity using the WT strain (Fig. 2F).
Phenotypic andgenetic reversionof theAI45dup-containing
mutant to wild type following blood infection. The duplication
of GCGATT in cps4E results in the formation of a short sequence
repeat (DR2) (Fig. 3A), which we predicted might be unstable in a
manner akin to phase-variable loss of a repeat through slipped-
strand mispairing (53–55). Note that another direct repeat (DR1)
is present upstream and overlaps DR2 (Fig. 3A). The loss of one
repeat (either DR1 or DR2) would be expected to restore Cps4E to
the wild-type sequence and thus wild-type capsule expression and
virulence during sepsis. Therefore, we tested the AI45dup-con-
taining mutant strain in this in vivo niche to determine if, under
this selective pressure, it is capable of reverting back to its fully
encapsulated state. For these experiments, we colony purified four
independent AI45dup clones and injected each i.p. into two Swiss
Webster mice at 108 CFU per mouse. After 24 h, mice were eutha-
nized, bacteria were recovered from the blood and plated on TSA,
and colony morphologies were examined using oblique transmit-
ted light microscopy. Each mouse output yielded a mixture of
transparent and opaque colonies. For each mouse, two colonies
were isolated and restreaked to confirm colony phenotype, and
DNA was prepared for sequencing of the cps4E gene. A total of 26
colonies from 13 mice in two independent experiments were an-
alyzed in this portion of the study.
The data from these experiments revealed that all 16 morpho-
logically opaque colonies had the Cps4E amino acid sequence re-
stored to the wild type, while transparent colonies retained the
parental AI45dup sequence. Interestingly, among opaque colonies
with the restored Cps4E sequence, there were two distinct cps4E
genotypes, either precise deletion of one DR1 repeat (revertant
genotype 1) or precise deletion of one DR2 repeat (revertant ge-
notype 2) (Fig. 3A). In epithelial cell adhesion assays, we deter-
mined that the opaque revertants exhibited the expected poor
FIG 2 In vitro and in vivo characterization of the AI45dup cps4E mutant. For all experiments described below, bacteria were grown to mid-exponential phase in
THY-Oxyrase and then subjected to the appropriate assay. WT TIGR4, TIGR4cps, and AI45dup bacteria were stained with anti-capsular polysaccharide
(serotype 4) (A) or anti-P-Cho (TEPC-15) (B) antibodies and subjected to FACS analysis. Data for capsule levels are representative histogram plots from 4
independent experiments with similar results. Data for exposed P-Cho are from two independent experiments; the horizontal lines are the means. Data are
presented as mean fluorescence intensity (MFI). (C) For abiotic, static biofilm experiments, bacteria were washed in 1 PBS, diluted to an OD600 of 0.01, plated
in 96-well plates, and incubated at 37°C with CO2 for 18 h. Data are from one experiment representative of 3 independent experiments and are means and
standard deviations (SD) from five technical replicates. (D) In epithelial adhesion experiments, bacteria were added to a monolayer of A549 human lung
carcinoma epithelial cells at a multiplicity of infection (MOI) of 50:1 and incubated for 2 h at 37°C. Adherent bacteria were recovered and enumerated on blood
agar plates, and results are presented as percent bound normalized to the number of input bacteria. Data are from 4 independent experiments, with the horizontal
bar denoting the mean. (E) For C3 deposition experiments, bacteria were opsonized with infant rabbit serum for 30 min at 37°C with rolling, stained with a
FITC-conjugated anti-C3 complement antibody, and analyzed by flow cytometry. Data are representative histograms from 4 independent experiments. *, P
0.05, **, P 0.01, and ***, P 0.001, compared to TIGR4 using one-way ANOVA. (F) Virulence of WT TIGR4 and AI45dup-containing strains was tested in
a blood model of infection. For each strain, 103 CFU were injected i.p. into Swiss Webster mice. After 18 h, mice were euthanized, and bacterial counts in blood
were determined by plating for CFU. The horizontal bar shows the median for each group and each point represents an individual mouse. Open symbols indicate
a mouse that yielded no detectable CFU, and the lower dotted line represents the limit of detection. The exact P value was calculated using Student’s t test.
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binding phenotype identical to that of the WT TIGR4 strain (data
not shown).
We speculated that slipped-strand mispairing of the DNA
polymerase along the DR1 short sequence repeat may have led to
the initial spontaneous duplication event that gave rise to the
AI45dup-containing mutant strain. However, our failed attempt
to reproduce this mutant (described below) suggested that it is a
rare event. In contrast, under selective pressure in blood, the
AI45dup allele readily gave rise to reversion events involving de-
letion of one or the other repeat. We tested whether slipped-strand
mispairing was the mechanism responsible for reversion of the
cps4E gene by generating two “phase-locked” (PL) mutants in the
AI45dup background. These mutants had two (AI45dupPL2) or
three (AI45dupPL3) mutated nucleotides in the second DR2 re-
peat, while the amino acid sequence remained unchanged, and
care was taken not to introduce rare codons (Fig. 3B).
For these experiments, two colony-purified clones for each of
the AI45dupPL2 and AI45dupPL3 strains were inoculated into
two or three mice each via i.p. injection as described above. Sub-
sequently, in order to examine colony morphology, bacteria were
recovered from the blood and plated on TSA. All of the output
colonies examined, 21 colonies for AI45dupPL2 and 16 colonies
for AI45dupPL3, demonstrated a transparent colony phenotype,
and each retained the parental cps4E sequence. These data suggest
that the DR2 repeat is required for effective phenotypic and ge-
netic reversion of the AI45dup-containing mutant. Because
phase-locking of DR2 abrogated both types of deletion events, we
did not test phase-locked mutations in DR1, though presumably
this repeat is necessary in combination with the DR2 repeat for
deletion of one DR1 repeat (revertant genotype 1) via slipped-
strand mispairing.
Serial passaging of TIGR4 and characterization of generated
capsule mutants. To determine if the duplication of GCGATT in
cps4E was a frequent mutational event, we serially passaged 96
clones of WT TIGR4 in vitro in THY and on blood agar plates a
total of eight times. We hypothesized that growth under these
FIG 4 cps4E genotypes of the resulting reduced capsule mutants isolated from
in vitro passaging. (A) Twenty-six transparent colonies were identified and
colony purified onto new TSA plates to confirm their colony morphology. As
controls, unpassaged and opaque colonies were also studied. Genomic DNA
was isolated from these strains, and forward and reverse primers flanking cps4E
were used for PCR. (A) Sequencing results. (Top) Colony phenotype, number
of isolates of each colony phenotype sequenced, and the number of colonies
with mutations in cps4E. (Bottom) For the transparent colonies with muta-
tions in cps4E, the nature of the mutation and the phenotype conferred are
provided. (B) The topology of Cps4E was determined using the TMpred pro-
gram from the ExPASy Proteomics website (http://www.expasy.org/tools).
Depicted are the locations of the mutations, including the originally described
6-bp insertion. Mutants in bold were further characterized in subsequent ex-
periments.
FIG 3 Evaluating the reversibility of the AI45dup-containing mutant follow-
ing blood infection. (A) Genotype and corresponding translation of a portion
of the cps4E gene in the AI45dup-containing strain. The 6-bp sequence dupli-
cation is in lowercase. After in vivo blood infection, recovered output bacteria
were isolated and DNA was isolated from colonies with opaque and transpar-
ent morphology. The cps4E gene was sequenced and aligned with that from the
WT TIGR4 reference strain. All 16 of the analyzed opaque revertants that
recovered capsule had one of two different cps4E genotypes, precise excision of
either the 6-bp duplication (DR2; 6 of 16 colonies) or of the upstream se-
quence, AATTGC (DR1; 10 of 16 colonies). All 10 of the analyzed transpar-
ent colonies retained the second DR2 repeat. (B) Genotype and corresponding
translation of a portion of cps4E in the AI45dup, AI45dup PhaseLock 2
(AI45dupPL2), and AI45dupPL3 strains. Following i.p. blood infection with
either AI45dupPL2 or AI45dupPL3 strains, all recovered output bacteria failed
to revert and retained their phase-locked genotype and transparent phenotype.
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conditions would select for less encapsulated variants, since acap-
sular strains of pneumococcus exhibit a growth advantage in vitro
(40, 56). After serial passage, 26 of the 96 clones exhibited trans-
parent colony morphologies (Fig. 4A). In order to examine the
molecular basis of this phenotype, DNA was isolated from these
clones, along with 10 opaque control (unpassaged) and 33 opaque
(passaged) colonies, and cps4E was sequenced. Strikingly, 22 out
of 26 transparent colonies harbored mutations in cps4E, with 16 of
these mutations being unique (Fig. 4). However, none of these
mutants contained the originally described GCGATT sequence
duplication. Instead, the majority of the mutants contained single
missense mutations, while two mutants harbored a nonsense mu-
tation, and a single mutant possessed a 2-bp deletion resulting in a
frameshift and early stop codon (Fig. 4A and B). Based on the
predicted protein topology generated by the program TMpred,
the majority of the mutations were located in the cytoplasmic
portion of Cps4E. Two mutations mapped to the transmembrane
region, and a single mutation was present in the predicted extra-
cellular part of the protein (Fig. 4B). From these results, we con-
clude that the AI45dup transparent mutant arises from a rare du-
plication event but, once formed, is readily revertible back to an
opaque colony type when subjected to strong selection in an ani-
mal host.
Six representative mutants (Fig. 4B, boldface) were character-
ized with respect to capsule expression level and associated phe-
notypes. Flow-cytometric analysis revealed that four of the six
mutants had reduced capsule levels, while two mutants, the A42E
and G201S mutants, exhibited seemingly WT levels of capsule,
though there was a fair amount of variability observed in these two
mutants (Fig. 5A). When the mutants were tested for C3 comple-
ment deposition, all except the G201S mutant exhibited higher C3
deposition, consistent with their having reduced capsule expres-
sion (Fig. 5B). Finally, when they were tested in the murine model
of sepsis, which is the most stringent of the three assays for capsule
expression level, we observed that all six mutants were attenuated
(Fig. 5C). The G201S mutant was only mildly attenuated, consis-
tent with its near-wild-type capsule expression level.
To determine if the more frequent SNP class of mutations in
cps4E were also revertible, each mutant was subjected to the iden-
tical in vivopassaging scheme in the blood as detailed above for the
AI45dup-containing mutant. We predicted that the spontaneous
SNP mutations in cps4E would be less capable of doing so due to
the lack of short sequence repeats associated with them that could
revert by slipped-strand mispairing. Interestingly, despite main-
taining the SNP in cps4E (Table 2 ), the G201S strain was lethal at
the high dose used for this experiment, which may be due to its
near-wild-type level of capsule (Fig. 5A). Consistent with our hy-
pothesis, of the remaining SNP mutants, none could revert, with
the one exception of the Y89* strain (Table 2). All of the other
tested SNP mutants were either completely avirulent (no recov-
ered bacteria) or yielded low numbers of recovered bacteria, all of
which were transparent and maintained the mutation in cps4E
FIG 5 Characterization of a panel of cps4E capsule mutants obtained from serial passaging. Six representative cps4E mutants were selected for further in vitro and
in vivo characterization. Mid-exponential-phase bacteria were subjected to FACS analysis of capsule levels (A) and C3 complement deposition (B). For capsule
levels and C3 deposition, data are means and standard errors of the means (SEM) from three independent experiments. Capsule levels are presented as relative
units normalized to levels in WT TIGR4. (C) Each of the 6 cps4E mutants was tested for virulence in a blood model of infection. Mid-exponential-phase bacteria
were prepared and washed in 1 PBS, and103 CFU were injected i.p. into Swiss Webster mice. After 18 h, mice were euthanized, and blood was isolated via
cardiac puncture and plated on BA plated for enumeration of recovered bacteria. For all tested strains, except for the G201S strain, we failed to recover bacteria
after infection. The G201S strain was capable of infecting animals, but we recovered significantly fewer bacteria than with WT TIGR4. Each point represents an
individual animal, and the horizontal line denotes the median. The input number of bacteria and limit of detection for this experiment are indicated by the dotted
lines. Data were pooled from 2 independent experiments. *, P 0.05.
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(Table 2). Reversion of the Y89* strain was variable, occurring in
only half the animals. It is unclear to us why this SNP mutant was
capable of reverting.
Mutations in cpsE in a conjunctival isolate. Most pneumo-
coccal conjunctival infections are caused by acapsular or nontype-
able strains that lack most of the cps operon, which are referred to
as group I NT strains. However, in relatively rare group II NT
strains, the cps locus remains largely intact, though the strains are
acapsular (16-18, 21, 23, 57-60). Based on our observations above,
we hypothesized that the molecular mechanism responsible for
loss of capsule in group II NT conjunctival isolates was due to a
mutation(s) in cpsE. We tested this hypothesis using available iso-
lates lacking cps operon deletions; two serotype 19A conjunctival
isolates, one that was encapsulated (3526) and another that lacked
capsule (3105) (Fig. 6A, top). Upon comparing the sequence of
cpsE between these two strains, we discovered four missense mu-
tations in the acapsular strain. To determine if these mutations
were responsible for the acapsular phenotype, we swapped the
cpsE alleles between the two conjunctival strains. These experi-
ments revealed that this was sufficient to switch the capsular phe-
notypes (data not shown). Upon further examination, we deter-
mined that the missense mutation at base 1129, which changed an
arginine to a glycine at position 377 in the protein, was necessary
and sufficient for the acapsular phenotype. Of note, in the major-
ity of pneumococcal serotypes, including 19A, the CpsE protein is
455 amino acids, while in TIGR4 (serotype 4), it is a much smaller,
211-amino-acid protein. Specifically, by making the G377R mu-
tation in cpsE (yielding the 3105 G377R strain), we were able to
confer capsule upon the 3105 acapsular isolate. Conversely, the
3526 R377G mutation rendered the encapsulated isolate unencap-
sulated (Fig. 6A, bottom). Notably, this is the same critical amino
acid residue in CpsE identified in a serotype 18C acapsular naso-
pharyngeal isolate (40). Finally, we tested whether restoring cap-
sule to the acapsular conjunctival isolate was sufficient to make the
strain virulent in the blood. Consistent with capsule expression
level, the unencapsulated conjunctival isolate 3105 was com-
pletely avirulent at a dose of 108 CFU/mouse, while the 3105
G377R encapsulated isogenic derivative was lethal in mice at the
same dose (Fig. 6B).
DISCUSSION
Several previous studies demonstrated that pneumococcus needs
to modulate levels of capsular polysaccharide in order to success-
fully colonize different host niches, including the nasopharynx,
lung, blood, and conjunctiva (1, 7, 16, 61). However, it is still
incompletely understood how this is accomplished: a phosphore-
lay system comprised of CpsB, CpsC, and CpsD and transcrip-
tional regulation of capsule genes comprise two levels of control of
capsule levels (33–35, 62, 63). This study and work by others sup-
ports the notion that there exists another potential layer of con-
trol, involving mutations in the gene encoding the initiating
glycosyltransferase, cpsE (39, 40). Our experiments using sero-
type-matched acapsular and encapsulated conjunctival isolates
support the idea that this level of control occurs in nature.
Our initial identification of a less encapsulated TIGR4 mutant
caused by a spontaneous 6-bp duplication in cps4E led to the hy-
pothesis that this phenotype arose due to slipped-strand mispair-
ing along a short sequence repeat immediately upstream. This
form of genome plasticity was reported for other genes in pneu-
mococcus (55), as well as in other mucosal pathogens, including
Neisseria species, Streptococcus agalactiae, Haemophilus influen-
zae, and Helicobacter pylori (53, 54, 64–67). This notion was fur-
ther supported by similar observations made in three other pneu-
mococcal serotypes (types 3, 37, and 8), which also arose due to
spontaneous tandem sequence duplications in capsule biosynthe-
sis genes, including a 223-bp duplication in cps8E (41, 42). We
suspect that mutations in cpsE occur at a higher frequency, since
mutations in other serotype-specific genes are toxic, presumably
due to the accumulation of intracellular capsule precursors, which
are alleviated by a suppressor mutation in cpsE (68). In contrast to
FIG 6 The acapsular conjunctival isolate contains a mutation in cpsE, and a
residue at position 377 controls the phenotype. (A) (Top) Encapsulated (3526)
and acapsular (3105) serotype 19A conjunctival isolates were grown to mid-
exponential phase in THY-Oxyrase, stained with India ink, and visualized by
microscopy to verify their capsule status. Four missense mutations in cpsE in
strain 3105 were identified when its sequence was compared to that of strain
3526. Of particular importance are arginine 377 (strain 3526, encapsulated)
and glycine 377 (strain 3105, acapsular). (Bottom) Swapping a single amino
acid residue at position 377 is sufficient for controlling the capsular phenotype;
3526 R377G becomes acapsular, while 3105 G377R regains capsule. (B) The
virulence of strain 3105 (acapsular) and 3105 G377R (encapsulated) was tested
in a blood model of infection. For these experiments, each strain was grown to
mid-exponential phase in THY-Oxyrase, washed in 1 PBS, and 108 CFU
were injected i.p. into Swiss Webster mice. After 18 h mice, were euthanized,
and blood was collected via cardiac puncture and plated on BA for enumera-
tion of bacteria. While strain 3105 (acapsular) was completely avirulent, its
encapsulated counterpart, 3105 G377R, was capable of causing disease at this
infectious dose. Each point represents an individual mouse. Open symbols
indicate mice that yielded no detectable CFU, and the dashed line represents
the limit of detection.
TABLE 2 Genotypes and colony phenotypes of parental cps4E mutants
and output bacteria after blood infection
Mutation in
Cps4E
Colony
phenotype
of parental
strain
cps4E genotype after
blood infection
Colony phenotype
after blood infection
A42E Transparent Maintains SNP Transparent
A79E Transparent Maintains SNP Transparent
Y89* Transparent Reverts to WT allele Opaque
D141* Transparent Avirulent or
maintains SNP
Avirulent/maintains
SNP; transparent
A156V Transparent Avirulent NAa
G201S Transparent Maintains SNP;
reduced virulence
Transparent
a NA, not applicable. Since the A156V mutant strain was completely avirulent in the
blood, it was not possible to determine the colony phenotype of recovered bacteria.
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a complete loss of capsule reported for these strains, the AI45dup-
containing mutant retained a low level of capsular polysaccharide.
This suggests that this two-amino-acid-duplication mutant re-
tains some glycosyltransferase activity. A thorough analysis of cpsE
in D39 (serotype 2) identified several residues in the extracyto-
plasmic loop (amino acids 117 to 264) and cytoplasmic tail
(amino acids 284 to 455) that were critical for glycosyltransferase
activity (39). In D39 and most other serogroups, including 19A,
CpsE is a large protein, approximately 455 amino acids, while
TIGR4 is unique in coding for a smaller CpsE protein, of 211
amino acids. However, the TIGR4 CpsE is highly homologous
(33% identity) across its entire length to the C-terminal half of
these longer CpsE proteins, which includes their final transmem-
brane portion and cytoplasmic tail, believed to have a glycosyl-
transferase function. Consistent with this, spontaneous null mu-
tations in the TIGR4, D39, and 19A cpsE genes all cluster
predominately in the portion corresponding to this C-terminal
cytoplasmic tail (39; also this study).
Pneumococcal strains with reduced levels of capsular polysac-
charide were previously shown to more effectively form biofilm
structures and adhere to host epithelial cells (10, 15, 69). In sup-
port of these findings, the AI45dup-containing strain exhibited an
enhanced ability to form static biofilms in vitro and adhere to a
human epithelial cell line. Additionally, a reduction in capsule
level was found to correlate with more exposed P-Cho and in-
creased susceptibility to C3 complement deposition (7, 48, 51),
and we showed that this is true as well for the AI45dup-containing
strain. The AI45dup-containing mutant was completely avirulent
in a mouse model of sepsis. In addition to C3 complement-medi-
ated opsonophagocytic killing, high concentrations of C-reactive
protein (CRP) found in the blood can bind exposed P-Cho resi-
dues present in the AI45dup-containing strain and initiate the
classical complement cascade, likely resulting in complete clear-
ance of the mutant (51, 70).
Phase variation is a heritable and reversible genetic event that
occurs at a relatively high frequency, which results in phenotypic
heterogeneity within a population (71, 72). Slippage of the DNA
polymerase along short sequence repeats, referred to as slipped-
strand mispairing, is a major mechanism of phase variation in
bacteria. The AI45dup mutation fit the phase variable criterion of
being reversible, since after one passage in the bloodstream of
mice, we readily isolated two types of repeat sequence deletion
mutants that restored Cps4E to the wild-type amino acid sequence
with concomitant restoration of capsule expression. Furthermore,
by generating phase-locked mutants and showing that these were
incapable of reverting, we hypothesize that reversion of the
AI45dup-containing mutant occurs by a slipped-strain mispair-
ing mechanism.
Despite our findings that the AI45dup mutation fulfilled the
requirement of being reversible, it was determined that the dupli-
cation event that gave rise to this mutant in the first place is rare,
being undetectable among a large panel of spontaneous mutants
selected for having reduced capsule expression. Thus, we conclude
that the AI45dup mutation is not a true phase-variable allele in
pneumococcus. Nevertheless, in our attempt to reisolate the
AI45dup mutation through selection, we identified several strains
with unique SNPs in cps4E resulting in missense and nonsense
mutations that reduced or in some cases abrogated capsule ex-
pression. Analysis of a subset of these mutants revealed that levels
of capsular polysaccharide and extent of C3 complement deposi-
tion could serve as a predictor of virulence in the blood. These
findings align with those of other studies reporting that capsule
serves as a critical barrier that impedes C3 deposition and that
more encapsulated strains (e.g., opaque variants) are more inva-
sive and/or pathogenic in the blood (7, 9, 73). Additional studies
revealed that in contrast to the AI45dup-containing mutant, with
the exception of the Y89* strain, the vast majority of the cps4E
point mutants were incapable of reverting or suppressing their
mutation to restore capsule level and virulence. In half of the an-
imals (4 out of 8) infected with the Y89* strain, we recovered
bacteria with the wild-type cps4E allele. Since there were no obvi-
ous DNA sequences surrounding this mutation that would be
susceptible to slipped-strand mispairing, it is difficult to speculate
why this particular SNP mutant could revert. Overall, our results
indicate that the spontaneous mutations in cpsE observed in this
study are not phase variable but instead may serve as a form of
adaptive mutation by reducing or eliminating capsule production.
In order to determine if our studies were applicable to clinically
relevant strains, we obtained two serotype 19A conjunctival iso-
lates, since conjunctivitis is often caused by acapsular pneumo-
coccal strains (16, 18). Indeed, we found that a single missense
mutation in the cpsE gene was responsible for the acapsular phe-
notype. It would be informative to evaluate additional conjuncti-
val isolates for mutations in cpsE. However, the fact that the ma-
jority of acapsular conjunctival isolates completely lack the cps
operon (21-23, 74) makes a study of this nature difficult to under-
take.
In conclusion, this study revealed that mutations in cpsE,
which encodes the initiating glycosyltransferase, ranging from
spontaneous sequence duplication to nonsense and missense mu-
tations, were capable of reducing capsule level to various degrees.
We propose that these mutations are adaptive in that they provide
an additional layer of adjusting capsular polysaccharide expres-
sion to allow optimal pneumococcal colonization in niches such
as the conjunctiva, where capsule is a detriment.
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